Prospective monitoring of plasma abemaciclib in breast cancer patients: associations with age and adverse events. Ikegami K, Makihara RA, Katsuya Y, Suzuki T, et al. Cancer Chemother Pharmacol 2026;96:3.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ikegami K, Makihara RA, Katsuya Y, Suzuki T, et al. Prospective monitoring of plasma abemaciclib in breast cancer patients: associations with age and adverse events. Cancer Chemother Pharmacol 2026;96:3.
PMID: 41484396